CSPM EDP Sciences logo
Access to submission and peer review system
Search
Menu
All issues Volume 3 (2022) Vis Cancer Med, 3 (2022) 1 References
Open Access
Issue
Vis Cancer Med
Volume 3, 2022
Article Number 1
Number of page(s) 5
DOI https://doi.org/10.1051/vcm/2022001
Published online 01 March 2022
  1. Zhang S, Sun K, Zheng R, et al. Cancer incidence and mortality in China, 2015. Journal of the National Cancer Center 2021;1(1):2–11. [CrossRef] [Google Scholar]
  2. Qian CN. At-home cancer screening: a solution for China and other developing countries with a large population and limited number of healthcare practitioners. Chinese Journal of Cancer. 2017;36(1):68. [CrossRef] [PubMed] [Google Scholar]
  3. Chen W, Zheng R, Baade PD, et al. Cancer statistics in China 2015. CA: A Cancer Journal for Clinicians. 2016;66(2):115–132. [CrossRef] [PubMed] [Google Scholar]
  4. Chen W, Zheng R, Zhang S, et al. Cancer incidence and mortality in China, 2013. Cancer Letters. 2017;401:63–71. [CrossRef] [PubMed] [Google Scholar]
  5. Zeng H, Chen W, Zheng R, et al. Changing cancer survival in China during 2003–15: a pooled analysis of 17 population-based cancer registries. Lancet Glob Health. 2018;6(5):e555–e567. [CrossRef] [PubMed] [Google Scholar]
  6. Guo LL, Wang HY, Zheng LS, et al. Metastasis of nasopharyngeal carcinoma: What we know and do not know. Visualized Cancer Medicine. 2021;2:13. [Google Scholar]
  7. Feng RM, Zong YN, Cao SM, et al. Current cancer situation in China: Good or bad news from the 2018 Global Cancer Statistics? Cancer Communications. 2019;39(1):22. [CrossRef] [Google Scholar]
  8. Sun D, Li H, Cao M, et al. Cancer burden in China: trends, risk factors and prevention. Cancer Biology & Medicine. 2020;17(4):879–895. [CrossRef] [PubMed] [Google Scholar]
  9. Barta JA, Powell CA, Wisnivesky JP, Global epidemiology of lung cancer. Annals of Global Health. 2019;85(1):100–202. [CrossRef] [PubMed] [Google Scholar]
  10. Wood DE, Kazerooni EA, Baum SL, et al. Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. 2018;16(4):412–441. [CrossRef] [PubMed] [Google Scholar]
  11. Cao M, Chen W, Epidemiology of lung cancer in China. Thoracic Cancer. 2019;10(1):3–7. [CrossRef] [PubMed] [Google Scholar]
  12. He J, Li N, Chen W, et al. China guideline for the screening and early detection of lung cancer (2021 Beijing). Zhonghua Zhong Liu Za Zhi. 2021;43(3):243–268. [PubMed] [Google Scholar]
  13. Guo LW,Liu SZ,Zhang SK, et al. Analysis of the efficacy of lung cancer screening in urban areas of Henan Province by low-dose computed tomography from 2013 to 2017. Zhonghua zhong liu za zhi [Chinese Journal of Oncology] 2020;42(2):155–159. [PubMed] [Google Scholar]
  14. Zhao S, Wu N. Early detection of lung cancer: Low-dose computed tomography screening in China. Thoracic Cancer. 2015;6(4):385–389. [CrossRef] [PubMed] [Google Scholar]
  15. Lawal O, Agbakwuru A, Olayinka OS, et al. Thyroid malignancy in endemic nodular goitres: prevalence, pattern and treatment. European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2001;27(2):157–161. [Google Scholar]
  16. Du L, Wang Y, Sun X, et al. Thyroid cancer: trends in incidence, mortality and clinical-pathological patterns in Zhejiang Province, Southeast China. BMC Cancer. 2018;18(1):291. [CrossRef] [PubMed] [Google Scholar]
  17. Du L, Zhao Z, Zheng R, et al. Epidemiology of thyroid cancer: Incidence and mortality in China, 2015. Frontiers in Oncology. 2020;10:1702. [CrossRef] [PubMed] [Google Scholar]
  18. Davies L, Welch HG. Current thyroid cancer trends in the United States. JAMA Otolaryngology – Head and Neck Surgery. 2014;140(4):317–322. [CrossRef] [PubMed] [Google Scholar]
  19. Dal Maso L, Bosetti C, La Vecchia C, et al. Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors. Cancer Causes and Control: CCC. 2009;20(1):75–86. [CrossRef] [PubMed] [Google Scholar]
  20. Schonfeld SJ, Lee C, Berrington de González A. Medical exposure to radiation and thyroid cancer. Clinical Oncology (Royal College of Radiologists (Great Britain)). 2011;23(4):244–250. [CrossRef] [PubMed] [Google Scholar]
  21. Cho YA, Kim J. Dietary factors affecting thyroid cancer risk: A meta-analysis. Nutrition and Cancer. 2015;67(5):811–817. [CrossRef] [PubMed] [Google Scholar]
  22. Brito JP, Al Nofal A, Montori VM, et al. The impact of subclinical disease and mechanism of detection on the rise in thyroid cancer incidence: a population-based study in Olmsted County, Minnesota during 1935 through 2012. Thyroid: Official Journal of the American Thyroid Association. 2015;25(9):1–2. [CrossRef] [PubMed] [Google Scholar]
  23. O’Grady TJ, Gates MA, Boscoe FP. Thyroid cancer incidence attributable to overdiagnosis in the United States 1981–2011. International Journal of Cancer. 2015;137(11):2664–2673. [CrossRef] [PubMed] [Google Scholar]
  24. Vaccarella S, Dal Maso L, Laversanne M, et al. The impact of diagnostic changes on the rise in thyroid cancer incidence: a population-based study in selected high-resource countries. Thyroid: Official Journal of the American Thyroid Association. 2015;25(10):1127–1136. [CrossRef] [PubMed] [Google Scholar]
  25. Poudineh M, Sargent EH, Pantel K, et al. Profiling circulating tumour cells and other biomarkers of invasive cancers. Nature Biomedical Engineering. 2018;2(2):72–84. [CrossRef] [PubMed] [Google Scholar]
  26. Cai X, Janku F, Zhan Q, et al. Accessing genetic information with liquid biopsies. Trends in Genetics: TIG. 2015;31(10):564–575. [CrossRef] [Google Scholar]
  27. Campos-Carrillo A, Weitzel JN, Sahoo P, et al. Circulating tumor DNA as an early cancer detection tool. Pharmacology & Therapeutics. 2020;207:107458. [CrossRef] [PubMed] [Google Scholar]
  28. Sabatino SA, White MC, Thompson TD, et al. Cancer screening test use – United States, 2013. MMWR Morbidity and Mortality Weekly Report. 2015;64(17):464–468. [PubMed] [Google Scholar]
  29. Damiani G, Basso D, Acampora A, et al. The impact of level of education on adherence to breast and cervical cancer screening: Evidence from a systematic review and meta-analysis. Preventive Medicine. 2015;81:281–289. [CrossRef] [Google Scholar]
  30. Carney PA, O’Malley J, Buckley DI, et al. Influence of health insurance coverage on breast, cervical, and colorectal cancer screening in rural primary care settings. Cancer. 2012;118(24):6217–6225. [CrossRef] [PubMed] [Google Scholar]
  31. Sabatino SA, Lawrence B, Elder R, et al. Effectiveness of interventions to increase screening for breast, cervical, and colorectal cancers: nine updated systematic reviews for the guide to community preventive services. American Journal of Preventive Medicine. 2012;43(1):97–118. [CrossRef] [PubMed] [Google Scholar]
  32. Stange KC, Breslau ES, Dietrich AJ, et al. State-of-the-art and future directions in multilevel interventions across the cancer control continuum. Journal of the National Cancer Institute Monographs. 2012;2012(44):20–31. [CrossRef] [PubMed] [Google Scholar]
  33. Taplin SH, Anhang Price R, Edwards HM, et al. Introduction: Understanding and influencing multilevel factors across the cancer care continuum. Journal of the National Cancer Institute Monographs. 2012;2012(44):2–10. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.